Cryptotanshinone, a novel tumor angiogenesis inhibitor, destabilizes tumor necrosis factor‐α mRNA via decreasing nuclear–cytoplasmic translocation of RNA‐binding protein HuR

Author:

Zhu Zhijie12,Zhao Yang12,Li Junbo3,Tao Li12,Shi Peiliang3,Wei Zhonghong12,Sheng Xiaobo12,Shen Dandan12,Liu Zhaoguo12,Zhou Liang12,Tian Chao12,Fan Fangtian12,Shen Cunsi12,Zhu Pingting12,Wang Aiyun124,Chen Wenxing124,Zhao Qingshun3,Lu Yin124

Affiliation:

1. School of PharmacyNanjing University of Chinese MedicineNanjing210023China

2. Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia MedicaNanjing University of Chinese MedicineNanjing210023China

3. Model Animal Research Center of Nanjing UniversityNanjing210061China

4. Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of TumorNanjing University of Chinese MedicineNanjing210023China

Funder

National Natural Science Foundation of China

National Science Foundation

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Reference56 articles.

1. Angiogenesis: Basic and clinical aspects;Ribatti D;Ital J Anat Embryol,2002

2. Role of angiogenesis in tumor growth and metastasis;Folkman J;Elsevier,2002

3. Clinical translation of angiogenesis inhibitors

4. Angiogenesis

5. Tumour necrosis factor and cancer

Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3